Journal of Orthopaedic Surgery and Research, 2017 · DOI: 10.1186/s13018-017-0578-z · Published: March 24, 2017
Central pain (CP) is a common problem after spinal cord injury (SCI). This study looks at how iron overload in the brain and activation of microglia (a type of brain cell) might play a role in CP development after SCI. Rats with SCI were given different treatments: an iron-chelating agent, minocycline (a microglia inhibitor), or a nitric oxide synthase inhibitor. The researchers then measured pain behavior, iron levels, and signs of microglia activation in the rats' brains. The study found that SCI led to iron overload in certain brain regions, which then activated microglia. This activation seems to be linked to the NF-κB signaling pathway, which can cause inflammation and nerve damage, ultimately contributing to CP.
Targeting iron overload and microglia activation could provide new avenues for treating central pain after spinal cord injury.
Iron-chelating agents, NF-κB inhibitors, and microglia inhibitors may offer effective strategies for relieving CP in SCI patients.
Further research is required to fully elucidate the mechanisms of CP and explore additional therapeutic targets.